Science Seen | Sneak Preview
Specimen courtesy of Andrew Koff, Anxo Vidal Image courtesy of Tim Bromage, Nancy Yeh | |
![]() | |
| | |||||||||||
Not recommended | 1 | 2 | 3 | 4 | 5 | Highly recommended | |||||
Please register your vote | |||||||||||
Science Seen | Sneak Preview Specimen courtesy of Andrew Koff, Anxo Vidal Image courtesy of Tim Bromage, Nancy Yeh SNEAK PREVIEW: Using a technique called AutoMontage, which combines multiple, partially focused digital images, researchers captured skeletal development in a 16 1/2-day-old knockout mouse embryo, in which a gene coding for an enzyme responsible for cell division was inactivated. The embryo was stained to reveal cartilage (blue) and mineralized bone (red). function sen
Specimen courtesy of Andrew Koff, Anxo Vidal Image courtesy of Tim Bromage, Nancy Yeh | |
![]() | |
| | |||||||||||
Not recommended | 1 | 2 | 3 | 4 | 5 | Highly recommended | |||||
Please register your vote | |||||||||||


The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST

Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.